ANI制药公司开始在马萨诸塞州总医院进行凝胶试验,以治疗古塔。 ANI Pharmaceuticals begins trial of gel to treat gout at Massachusetts General Hospital.

ANI制药公司在马萨诸塞州总医院启动了第4阶段临床试验,以测试两剂净化的Corriftin Gel,用于治疗急性甲状腺炎。 ANI Pharmaceuticals has launched a Phase 4 clinical trial at Massachusetts General Hospital to test two dose levels of Purified Cortrophin Gel for treating acute gout flares. 该研究由Hyon Choi博士牵头,旨在提供更多关于凝胶有效性和安全性的数据,重点是在一周内减少160名患者的疼痛和其他结果。 The study, led by Dr. Hyon Choi, aims to provide more data on the gel's effectiveness and safety, focusing on pain reduction and other outcomes in up to 160 patients over a week. 这种研究可以帮助医生更好地管理痛风,这个痛苦的状况影响着数百万人。 This research could help doctors better manage gout, a painful condition affecting millions.